Web Results

Meda Pharmaceuticals Inc. et al v. Teva Pharmaceuticals USA, Inc.


Meda Pharmaceuticals Inc. et al v. Teva Pharmaceuticals USA, Inc. 1:15-cv- 00785; Filed: 09/08/2015; Case Updated Daily; Latest Docket Entry: 10/14/2016 ...

Btg International Limited et. al. v. Glenmark Pharmaceuticals Inc ...


BTG INTERNATIONAL LIMITED et al v. GLENMARK PHARMACEUTICALS INC., USA et al. 2:16-cv-03743; Filed: 06/24/2016; Case Updated Daily; Latest ...

Reference for Contraception Lecture - UNMC


Ness RB, et al. ... Silvera SA, et al Cancer Causes Control. 2005 ... Ortho-McNeil Pharmaceutical Inc; 2008Jan. ... Organon USA Inc. 2006Jul. .... V; Wilson JC.

PDF(1417K) - Wiley Online Library


Sep 10, 2007 ... Corp, Nycomed Group, Organon USA Inc, Pfizer Inc, Procter &. Gamble ..... in the zoledronic acid group versus placebo: osteoid thick- ness (p. 0.009), median osteoid ..... recent study by Stepan et al.,(24) bone biopsies obtained from 38 ..... Viereck V, Emons G, Lauck V, Frosch KH, Blaschke S,. Grundker C ...

Original research by: Doug Henderson, JD - Solari


Pfizer Inc announced today that it ha reached ... USA in a complex civil court dispute its messy ... Merck and Schering Plough have ent ...... reserves for Ortho Evra sufferers. CONFIDENTIAL. arned h nes than blood suits ... Felicia Wrice, et al. v.

Identifying Risk for Attrition during Treatment for Depression - Karger


Sep 8, 2009 ... Questions 1 and 2 were derived from the approach suggested by Leon et al. .... ness of fit test, the model fits well. Dropouts ... vs. 10%) and 3 times as likely to have reported uncertain/ negative rather than positive intent at week 2 (20 vs. 7% ). ..... Neuronetics, Ono Pharmaceutical, Organon USA Inc., Otsuka.

Evaluation of commercial HTLV-1 test kits by a standard ... - NCBI


a United Biomedical Inc., New York, NY, USA. b Fujirebio Inc. ... gapore, Singapore; Eisai Corp., Tokyo, Japan; Organon Teknika. Corp., Durham, NC ... deviation) developed by Crofts et al. (21) was calcu- .... Usefulness of the standard HTL V-1 serum panel .... nes par le HTLV-1 a reduit la transmission de ce virus par voie ...

Oh et al. - The Journal of Cell Biology - The Rockefeller University ...


Jan 18, 2010 ... Nuclear export of NES-containing proteins is dependent on .... from the vector pEGFP-N1, pYFP-N1, and pDsRed-N1 (Takara Bio Inc.), ... The indicated amounts of mRNAs, MO, or H2O were injected with a micromanipulator ( Narishige USA) ... Institutes of Health grant GM 080527 and a grant from Organon.

Recent Advances in Understanding and Mitigating Adipogenic - NCBI


Jun 28, 2012 ... Data from commercially insured (Haupt et al., 2009) and Medicaid ..... Inc., Organon Pharmaceuticals USA Inc., Schering-Plough/Merck, Vivus, Inc., ... Ader M., Kim S. P., Catalano K. J., Ionut V., Hucking K., Richey J. M., Kabir M., ..... Munroe P. B., Morris A. D., Ness A. R., Neville M. J., Nica A. C., Ong K. K., ...

Ligand Selectivity of Gonadotropin Receptors - The Journal of ...


Jan 21, 2003 ... Organon Inc., 5342 CC Oss, The Netherlands. The difference in .... Biology, Inc. Printed in U.S.A. .... hFSH-R (see Tables II, III, and V for the details of which residues were replaced). ... according to Chen et al. (18) with minor .... ness to hFSH was decreased significantly in hFSH-R/Lß8 (5- fold; p. 0.05) ...

More Info

Teva Pharmaceuticals USA Inc. et al v. Amneal Pharmaceuticals LLC


Teva Pharmaceuticals USA Inc. et al v. Amneal Pharmaceuticals LLC. 1:15-cv- 00124; Filed: 02/03/2015; Case Updated Daily; Latest Docket Entry: 03/27/2015 ...

Volume 53 - Taxpayers Against Fraud


Jul 15, 2009 ... Antidiscrimination Ctr. of Metro New York, Inc. v. ... Hypoguard USA, Inc., ... Organon, Inc., ... U.S. v. Axia College Online, Western Int'l Univ., et al., ...... ness enterprise (“DBE”) report to the Department of Transportation (“DoT”),.

PDF(644K) - Wiley Online Library


Boston, MA 02114, USA. Tel: 617-726-8895; ... ness and sickness [1], or emotional and psychotic disorders [2]. To address ..... The cause-correction hypothesis, supported by the Tang et al. .... tains multiple, dynamic subsystems ( e.g., 5HT1 vs. 5HT2), an- ..... tion 21; Orexigen Therapeutics, Inc.; Organon Pharmaceuticals;.